These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 25492486

  • 1. Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression.
    Yang X, Sun D, Tian Y, Ling S, Wang L.
    Tumour Biol; 2015 Apr; 36(4):2957-64. PubMed ID: 25492486
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Zhai B, Jiang X, He C, Zhao D, Ma L, Xu L, Jiang H, Sun X.
    Tumour Biol; 2015 Apr; 36(4):2323-34. PubMed ID: 25416439
    [Abstract] [Full Text] [Related]

  • 3. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J.
    Oncotarget; 2016 Oct 25; 7(43):70504-70515. PubMed ID: 27655700
    [Abstract] [Full Text] [Related]

  • 4. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM, Tseng JT, Hong DY, Huang HS.
    Biochem J; 2011 Sep 01; 438(2):349-58. PubMed ID: 21649584
    [Abstract] [Full Text] [Related]

  • 5. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H.
    Cancer Lett; 2011 Feb 01; 301(1):75-84. PubMed ID: 21078540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C, Zhou R, Zhou Q, Chang Y, Jiang M.
    Life Sci; 2016 Dec 01; 166():34-40. PubMed ID: 27717846
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
    Cai X, Yu L, Chen Z, Ye F, Ren Z, Jin P.
    Cancer Biomark; 2020 Dec 01; 28(2):221-230. PubMed ID: 32280078
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Cui L, Gao B, Cao Z, Chen X, Zhang S, Zhang W.
    Mol Med Rep; 2016 Mar 01; 13(3):2032-8. PubMed ID: 26781180
    [Abstract] [Full Text] [Related]

  • 12. All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
    Wei J, Ye C, Liu F, Wang W.
    J Chemother; 2014 Dec 01; 26(6):348-52. PubMed ID: 25068185
    [Abstract] [Full Text] [Related]

  • 13. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L.
    Mol Cancer; 2014 May 31; 13():133. PubMed ID: 24884809
    [Abstract] [Full Text] [Related]

  • 14. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q, Li Y, Deng J, Zhang Z.
    Chem Biol Interact; 2015 Jan 25; 226():12-22. PubMed ID: 25499136
    [Abstract] [Full Text] [Related]

  • 15. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Jiang H, Ma Y, Chen X, Pan S, Sun B, Krissansen GW, Sun X.
    Cancer Sci; 2010 Apr 25; 101(4):975-83. PubMed ID: 20219070
    [Abstract] [Full Text] [Related]

  • 16. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Huang A, Yue D, Liao D, Cheng L, Ma J, Wei Y, Tong A, Cheng P.
    Oncol Rep; 2016 Dec 25; 36(6):3283-3290. PubMed ID: 27748945
    [Abstract] [Full Text] [Related]

  • 17. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
    Jiao J, Hong S, Zhang J, Ma L, Sun Y, Zhang D, Shen B, Zhu C.
    Cancer Lett; 2012 Jul 01; 320(1):96-103. PubMed ID: 22313545
    [Abstract] [Full Text] [Related]

  • 18. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, Hu H, Chen X, Huang J, Cheng J, Jing X.
    Oncol Rep; 2013 Nov 01; 30(5):2449-57. PubMed ID: 24008375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S, Ke Q, Liu Y, Li P, Cui X, Shen A, Cheng C.
    Med Oncol; 2009 Nov 01; 26(2):178-85. PubMed ID: 18937079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.